London Stock Exchange Notice Cancellation - Dechra Pharmaceuticals Plc (8867Z)

TIDMDPH

RNS Number : 8867Z

London Stock Exchange Notice

17 January 2024

NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON THE LONDON STOCK EXCHANGE

17/01/2024 - 08:00

At the request of the company the following securities have been cancelled from admission to trading on London Stock Exchange with effect from the time and date of this notice.

 
DECHRA PHARMACEUTICALS PLC 
213800J4UVB5OWG8VX82 
ORDINARY SHARES    (0963318)(GB0009633180)  DECA PHAR/PAR VTG FPD 0.01 
 OF 1P EACH FULLY 
 PAID 
                   -----------------------  --------------------------

If you have any queries relating to the above, please contact Market Operations at the London Stock Exchange on 020 7797 4310.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

SENGPUPAGUPCGWQ

(END) Dow Jones Newswires

January 17, 2024 03:00 ET (08:00 GMT)

Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Nov 2024 to Dec 2024